Cart
0

Smart Pills Technology Market by Technology (Capsule endoscopy, Workstations and recorders, Gastrointestinal Monitoring), and Application (Diagnosis, Monitoring) - Global Opportunity Analysis and Industry Forecast, 2014 - 2020

Get 20% Free Customization In This Report
LI_15707
Pages: 115
Jul 2016 | 3398 Views
 
Author's : Sharayu Dhabale
Tables: 61
Charts: 48
 

Global Smart Pill Technology Market is expected to garner $627.1 million by 2020, registering a CAGR of 21.2% during the forecast period 2015-2020.

Smart pill technology is a revolutionary technological innovation that has reduced the gap between healthcare and digital technology. Smart pills or Nootropics are basically medical devices and small embedded electronic appliances such as sensors, cameras and trackers. This electronic device can be easily swallowed and provides complete evaluation of the gastrointestinal tract (GIT). The emergence of these healthcare-cum-technology devices has addressed the soaring need of better diagnostics and monitoring. It has outperformed the conventional GI monitoring endoscopy with more convenient smart pill technology, which has now become the standard non-invasive diagnosis technique for motility disorders. Moreover, it helps physicians in real-time patient monitoring through remote controlling options.

The global smart pills technology market is expected to register a substantial growth in the future, owing to the increased prevalence of gastrointestinal diseases (such as motility disorders, colon cancer, obscure gastrointestinal bleeding and Crohns disease), sedentary lifestyle and high patient compliance on account of minimally invasive techniques. The advent of novel technologies such as catheter-less pH monitoring, ingestible sensors and wireless capsule based GI monitoring would foster an accelerated market growth. Capsule endoscopes provide complete examination of GI tract which consists of a complete view of stomach including esophagus, small intestine and large intestine. Such pharmaceutical capsules play a vital role in differentiating between the healthy and unhealthy cells like targeted smart drug delivery or a targeted therapy.

Collaborations between research institutions and companies, licensing agreements & partnerships amongst companies and augmented R&D investment on smart pills are some of the other factors boosting the market growth. Despite several advantages, factors such as high costs, limited technical know-how and low patient confidence are likely to restrain the growth of the market.

The report segments the smart pills technology market on the basis of technology, application and geography. On the basis of technology, the market is segmented into capsule endoscopy technology and gastrointestinal monitoring technology. Based on application, the market has been classified into diagnosis and monitoring. Geographic breakdown and deep analysis of each of the aforementioned segments have been included for North America, Europe, Asia Pacific and LAMEA. Comprehensive competitive assessment and profiles of major market players such as Proteus Digital Health, CapsoVision, Inc., Given Imaging, Inc., Olympus Corporation, Chongqing Jinshan Science & Technology Group Co. Ltd, and IntroMedic Co. Ltd have also been provided in the report.

Smart Pills Technology Market

Key Benefits

  • This report provides an extensive analysis of the current and emerging trends, share and size and dynamics in the global smart pills market
  • In-depth evaluation of smart drug has been done in this report by constructing market estimations for the key segments for the forecast period of 2014-2020
  • Geographically, the smart pills technology market is analyzed based on various regions such as North America, Europe, Asia Pacific and LAMEA
  • Exhaustive assessment is done for the industry by application such as diagnosis and monitoring
  • The studies evaluating competitive landscape and value chain have been taken into account in this report to help in understanding the competitive environment across the geographies
  • Detailed SWOT analysis of the prominent players is provided to illustrate the adopted business strategies
  • The report entails the detailed quantitative evaluation of the current and future estimations through 2014-2020 that assists in identifying the prevailing opportunities to capitalize on

Key Market Segments:

The Global Smart Pills technology market segmentation is illustrated below:

  • By Technology

    • Capsule endoscopy technology
      • Capsule endoscope
        • Small bowel capsule endoscope
        • Colon capsule endoscope
        • Esophagus capsule endoscope
      • Workstations and recorders
    • Gastrointestinal Monitoring Technology
      • Single parameter (pH) monitoring
      • Multi parameter (pH, temp, pressure) monitoring
  • By Application

    • Diagnosis
    • Monitoring
  • By Geography

    • North America
    • Europe
    • Asia-Pacific
    • LAMEA
 

Chapter: 1:    INTRODUCTION

1.1.    Report description
1.2.    Key benefits for stakeholders
1.3.    Key market segments
1.4.    Research methodology

1.4.1.    Secondary research
1.4.2.    Primary research
1.4.3.    Analyst tools & models

Chapter: 2:    EXECUTIVE SUMMARY

2.1.    CXO perspective

Chapter: 3:    MARKET OVERVIEW

3.1.    Market definition and scope
3.2.    Key findings

3.2.1.    Top investment pockets
3.2.2.    Top Winning Strategies

3.3.    Porter’s Five Forces analysis
3.4.    Market share analysis
3.5.    Market dynamics

3.5.1.    Drivers

3.5.1.1.    Rise in prevalence of gastrointestinal disorders
3.5.1.2.    Increase in the R&D investments in developing smart pills by manufacturers

3.5.2.    Restraints

3.5.2.1.    Lengthy timelines regarding approval of smart pills
3.5.2.2.    Higher costs associated with the smart pills

3.5.3.    Opportunity

3.5.3.1.    Increase in the technological advancements pertaining to smart pills

Chapter: 4:    SMART PILLS MARKET, BY APPLICATION

4.1.    Overview

4.1.1.    Market size and forecast

4.2.    Capsule Endoscopy

4.2.1.    Key trends and opportunities
4.2.2.    Market size and forecast

4.3.    Drug Delivery

4.3.1.    Key trends and opportunities
4.3.2.    Market size and forecast

4.4.    Patient Monitoring

4.4.1.    Key trends and opportunities
4.4.2.    Market size and forecast

Chapter: 5:    SMART PILLS MARKET, BY TARGET AREA

5.1.    Overview

5.1.1.    Market size and forecast

5.2.    Esophagus

5.2.1.    Market size and forecast

5.3.    Stomach

5.3.1.    Market size and forecast

5.4.    Small Intestine

5.4.1.    Market size and forecast

5.5.    Large Intestine

5.5.1.    Market size and forecast

Chapter: 6:    SMART PILLS MARKET, BY DISEASE INDICATION

6.1.    Overview

6.1.1.    Market size and forecast

6.2.    Esophagus Diseases

6.2.1.    Market size and forecast

6.3.    Small Bowel Disease

6.3.1.    Market size and forecast
6.3.2.    Crohn’s Disease

6.3.2.1.    Market size and forecast

6.3.3.    Small bowel tumors

6.3.3.1.    Market size and forecast

6.3.4.    Celiac disease

6.3.4.1.    Market size and forecast

6.3.5.    Others

6.3.5.1.    Market size and forecast

6.4.    Colon Diseases

6.4.1.    Market size and forecast

6.5.    Others

6.5.1.1.    Market size and forecast

Chapter: 7:    SMART PILLS MARKET, BY END USER

7.1.    Overview

7.1.1.    Market size and forecast

7.2.    Diagnostic Centers

7.2.1.    Market size and forecast

7.3.    Hospitals

7.3.1.    Market size and forecast

7.4.    Research Institutes

7.4.1.    Market size and forecast

Chapter: 8:    SMART PILLS MARKET, BY REGION

8.1.    Overview

8.1.1.    Market size and forecast

8.2.    North America

8.2.1.    Key trends and opportunities
8.2.2.    North America market size & forecast, by country
8.2.3.    North America market size & forecast, by application
8.2.4.    North America market size & forecast, by target area
8.2.5.    North America market size & forecast, by disease indication
8.2.6.    North America market size & forecast, by end user

8.2.6.1.    U.S. market size & forecast
8.2.6.2.    Canada market size & forecast
8.2.6.3.    Mexico market size & forecast

8.3.    Europe

8.3.1.    Key trends and opportunities
8.3.2.    Europe market size & forecast for smart pills market, by country
8.3.3.    Europe market size & forecast, by application
8.3.4.    Europe market size & forecast, by target area
8.3.5.    Europe market size & forecast, by disease indication
8.3.6.    Europe market size & forecast, by end user

8.3.6.1.    Germany market size & forecast
8.3.6.2.    France market size & forecast
8.3.6.3.    UK market size & forecast
8.3.6.4.    Italy market size & forecast
8.3.6.5.    Spain market size & forecast
8.3.6.6.    Russia market size & forecast
8.3.6.7.    Rest of Europe market size & forecast

8.4.    Asia-Pacific

8.4.1.    Key trends and opportunities
8.4.2.    Asia-Pacific market size & forecast, by country
8.4.3.    Asia-Pacific market size & forecast, by application
8.4.4.    Asia-Pacific market size & forecast, by target area
8.4.5.    Asia-Pacific market size & forecast, by disease indication
8.4.6.    Asia-Pacific market size & forecast, by end user

8.4.6.1.    Japan market size & forecast
8.4.6.2.    China market size & forecast
8.4.6.3.    India market size & forecast
8.4.6.4.    Australia market size & forecast
8.4.6.5.    South Korea market size & forecast
8.4.6.6.    Taiwan market size & forecast
8.4.6.7.    Rest of Asia-Pacific market size & forecast

8.5.    LAMEA

8.5.1.    Key trends and opportunities
8.5.2.    LAMEA market size & forecast, by country
8.5.3.    LAMEA market size & forecast, by application
8.5.4.    LAMEA market size & forecast, by target area
8.5.5.    LAMEA market size & forecast, by disease indication
8.5.6.    LAMEA market size & forecast, by end user

8.5.6.1.    Brazil market size & forecast
8.5.6.2.    South Africa market size & forecast
8.5.6.3.    Saudi Arabia market size & forecast
8.5.6.4.    Argentina market size & forecast
8.5.6.5.    Rest of LAMEA market size & forecast

Chapter: 9:    COMPANY PROFILES

9.1.    CapsoVision, Inc.

9.1.1.    Company overview
9.1.2.    Company snapshot
9.1.3.    Operating business segments
9.1.4.    Product portfolio
9.1.5.    Key strategic moves and developments

9.2.    Check-Cap Ltd.

9.2.1.    Company overview
9.2.2.    Company snapshot
9.2.3.    Operating business segments
9.2.4.    Product portfolio

9.3.    HQ.Inc.

9.3.1.    Company overview
9.3.2.    Company snapshot
9.3.3.    Operating business segments
9.3.4.    Product portfolio

9.4.    IntroMedic Co., Ltd

9.4.1.    Company overview
9.4.2.    Company snapshot
9.4.3.    Operating business segments
9.4.4.    Product portfolio
9.4.5.    Business performance
9.4.6.    Key strategic moves and developments

9.5.    JINSHAN Science & Technology

9.5.1.    Company overview
9.5.2.    Company snapshot
9.5.3.    Operating business segments
9.5.4.    Product portfolio
9.5.5.    Key strategic moves and developments

9.6.    Koninklijke Philips N.V.

9.6.1.    Company overview
9.6.2.    Company snapshot
9.6.3.    Operating business segments
9.6.4.    Product portfolio
9.6.5.    Business performance

9.7.    Medtronic plc

9.7.1.    Company overview
9.7.2.    Company snapshot
9.7.3.    Operating business segments
9.7.4.    Product portfolio
9.7.5.    Business performance
9.7.6.    Key strategic moves and developments

9.8.    OLYMPUS Corporation.

9.8.1.    Company overview
9.8.2.    Company snapshot
9.8.3.    Operating business segments
9.8.4.    Product portfolio
9.8.5.    Business performance

9.9.    Proteus Digital Health

9.9.1.    Company overview
9.9.2.    Company snapshot
9.9.3.    Operating business segments
9.9.4.    Product portfolio
9.9.5.    Key strategic moves and developments

9.10.    RF Co., Ltd.

9.10.1.    Company overview
9.10.2.    Company snapshot
9.10.3.    Operating business segments
9.10.4.    Product portfolio

LIST OF TABLES

TABLE 01.    GLOBAL SMART PILLS MARKET, BY APPLICATION 2017–2025 ($MILLION)
TABLE 02.    CAPSULE ENDOSCOPE AVAILABLE IN THE MARKET
TABLE 03.    GLOBAL SMART PILLS MARKET FOR CAPSULE ENDOSCOPY, BY REGION, 2017–2025 ($MILLION)
TABLE 04.    SMART CAPSULE FOR DRUG DELIVERY AVAILABLE IN THE MARKET
TABLE 05.    SMART PILLS MARKET FOR DRUG DELIVERY, BY REGION, 2017–2025 ($MILLION)
TABLE 06.    SMART PILLS FOR PATIENT MONITORING AVAILABLE IN THE MARKET
TABLE 07.    SMART PILLS MARKET FOR PATIENT MONITORING, BY REGION, 2017–2025 ($MILLION)
TABLE 08.    GLOBAL SMART PILLS MARKET, BY TARGET AREA, 2017–2025 ($MILLION)
TABLE 09.    SMART PILLS MARKET, FOR ESOPHAGUS, BY REGION, 2017–2025 ($MILLION)
TABLE 10.    SMART PILLS MARKET, FOR STOMACH, BY REGION, 2017–2025 ($MILLION)
TABLE 11.    SMART PILLS MARKET, FOR SMALL INTESTINE, BY REGION, 2017–2025 ($MILLION)
TABLE 12.    GLOBAL SMART PILLS MARKET, FOR LARGE INTESTINE, BY REGION, 2017–2025 ($MILLION)
TABLE 13.    GLOBAL SMART PILLS MARKET, BY DISEASE INDICATION, 2017–2025 ($MILLION)
TABLE 14.    GLOBAL SMART PILLS MARKET, FOR ESOPHAGUS DISEASES, BY REGION, 2017–2025 ($MILLION)
TABLE 15.    GLOBAL SMART PILL MARKET, FOR SMALL BOWEL DISEASES, BY REGION, 2017–2025 ($MILLION)
TABLE 16.    GLOBAL SMART PILL MARKET, FOR COLON DISEASES, BY REGION, 2017–2025 ($MILLION)
TABLE 17.    GLOBAL SMART PILLS MARKET, BY END USER, 2017–2025 ($MILLION)
TABLE 18.    GLOBAL SMART PILLS MARKET FOR DIAGNOSTIC CENTRES, BY REGION, 2017–2025 ($MILLION)
TABLE 19.    GLOBAL SMART PILLS MARKET FOR HOSPITALS, BY REGION, 2017–2025 ($MILLION)
TABLE 20.    GLOBAL SMART PILLS MARKET FOR RESEARCH INSTITUTES, BY REGION, 2017–2025 ($MILLION)
TABLE 21.    GLOBAL SMART PILLS MARKET, BY REGION, 2017–2025 ($MILLION)
TABLE 22.    NORTH AMERICA SMART PILLS MARKET, BY COUNTRY, 2017–2025 ($MILLION)
TABLE 23.    NORTH AMERICA SMART PILLS MARKET, BY APPLICATION, 2017–2025 ($MILLION)
TABLE 24.    NORTH AMERICA SMART PILLS MARKET, BY TARGET AREA, 2017–2025 ($MILLION)
TABLE 25.    NORTH AMERICA SMART PILLS MARKET, BY DISEASE INDICATION, 2017–2025 ($MILLION)
TABLE 26.    NORTH AMERICA SMART PILLS MARKET, BY END USER, 2017–2025 ($MILLION)
TABLE 27.    EUROPE SMART PILLS MARKET, BY COUNTRY, 2017–2025 ($MILLION)
TABLE 28.    EUROPE SMART PILLS MARKET, BY APPLICATION, 2017–2025 ($MILLION)
TABLE 29.    EUROPE SMART PILLS MARKET, BY TARGET AREA, 2017–2025 ($MILLION)
TABLE 30.    EUROPE SMART PILLS MARKET, BY DISEASE INDICATION, 2017–2025 ($MILLION)
TABLE 31.    EUROPE SMART PILLS MARKET, BY END USER, 2017–2025 ($MILLION)
TABLE 32.    ASIA-PACIFIC SMART PILLS MARKET, BY COUNTRY, 2017–2025 ($MILLION)
TABLE 33.    ASIA-PACIFIC SMART PILLS MARKET, BY APPLICATION, 2017–2025 ($MILLION)
TABLE 34.    ASIA-PACIFIC SMART PILLS MARKET, BY TARGET AREA, 2017–2025 ($MILLION)
TABLE 35.    ASIA-PACIFIC SMART PILLS MARKET, BY DISEASE INDICATION, 2017–2025 ($MILLION)
TABLE 36.    ASIA-PACIFIC SMART PILLS MARKET, BY END USER, 2017–2025 ($MILLION)
TABLE 37.    LAMEA SMART PILLS MARKET, BY COUNTRY, 2017–2025 ($MILLION)
TABLE 38.    LAMEA SMART PILLS MARKET, BY APPLICATION, 2017–2025 ($MILLION)
TABLE 39.    LAMEA SMART PILLS MARKET, BY TARGET AREA, 2017–2025 ($MILLION)
TABLE 40.    LAMEA SMART PILLS MARKET, BY DISEASE INDICATION, 2017–2025 ($MILLION)
TABLE 41.    LAMEA SMART PILLS MARKET, BY END USER, 2017–2025 ($MILLION)
TABLE 42.    CAPSOVISION: COMPANY SNAPSHOT
TABLE 43.    CAPSOVISION: OPERATING SEGMENTS
TABLE 44.    CAPSOVISION: PRODUCT PORTFOLIO
TABLE 45.    CHECK- CAP: COMPANY SNAPSHOT
TABLE 46.    CHECK-CAP OPERATING SEGMENTS
TABLE 47.    CHECK-CAP PRODUCT PORTFOLIO
TABLE 48.    HQ. COMPANY SNAPSHOT
TABLE 49.    HQ.: OPERATING SEGMENTS
TABLE 50.    HQ.: PRODUCT PORTFOLIO
TABLE 51.    INTROMEDIC: COMPANY SNAPSHOT
TABLE 52.    INTROMEDIC: PRODUCT PORTFOLIO
TABLE 53.    JINSHAN: COMPANY SNAPSHOT
TABLE 54.    JINSHAN: PRODUCT SEGMENTS
TABLE 55.    JINSHAN: PRODUCT PORTFOLIO
TABLE 56.    PHILIPS: COMPANY SNAPSHOT
TABLE 57.    PHILIPS: OPERATING SEGMENTS
TABLE 58.    PHILIPS: PRODUCT PORTFOLIO
TABLE 59.    MEDTRONIC: COMPANY SNAPSHOT
TABLE 60.    MEDTRONIC: OPERATING SEGMENTS
TABLE 61.    MEDTRONIC: PRODUCT PORTFOLIO
TABLE 62.    OLYMPUS: COMPANY SNAPSHOT
TABLE 63.    OLYMPUS: OPERATING SEGMENTS
TABLE 64.    OLYMPUS: PRODUCT PORTFOLIO
TABLE 65.    PROTEUS: COMPANY SNAPSHOT
TABLE 66.    PROTEUS: OPERATING SEGMENTS
TABLE 67.    PROTEUS: PRODUCT PORTFOLIO
TABLE 68.    RF CO., LTD: COMPANY SNAPSHOT
TABLE 69.    RF : PRODUCT SEGMENTS
TABLE 70.    RF CO.: PRODUCT PORTFOLIO

LIST OF FIGURES

FIGURE 01.    SMART PILLS MARKET SEGMENTATION
FIGURE 02.    TOP INVESTMENT POCKETS IN SMART PILLS MARKET, 2017
FIGURE 03.    TOP WINNING STRATEGIES, BY YEAR, 2016-2018*
FIGURE 04.    TOP WINNING STRATEGIES, BY DEVELOPMENT, 2016-2018* (%)
FIGURE 05.    TOP WINNING STRATEGIES, BY COMPANY, 2016-2018*
FIGURE 06.    HIGH BARGAINING POWER OF SUPPLIERS
FIGURE 07.    MODERATE BARGAINING POWER OF BUYERS
FIGURE 08.    LOW THREAT OF SUBSTITUTION
FIGURE 09.    HIGH THREAT OF NEW ENTRANT
FIGURE 10.    LOW COMPETITIVE RIVALRY
FIGURE 11.    MARKET SHARE ANALYSIS, 2017
FIGURE 12.    GLOBAL SMART PILLS MARKET: RESTRAINTS, DRIVERS, AND OPPORTUNITY
FIGURE 13.    GLOBAL SMART PILLS MARKET FOR CROHN’S DISEASE, 2017–2025 ($MILLION)
FIGURE 14.    GLOBAL SMART PILLS MARKET FOR SMALL BOWEL TUMORS, 2017–2025 ($MILLION)
FIGURE 15.    GLOBAL SMART PILLS MARKET FOR CELIAC DISEASE, 2017–2025 ($MILLION)
FIGURE 16.    GLOBAL SMART PILLS MARKET FOR CELIAC DISEASE, 2017–2025 ($MILLION)
FIGURE 17.    U.S. SMART PILLS MARKET, 2017-2025 ($ MILLION)
FIGURE 18.    CANADA SMART PILLS MARKET, 2017-2025 ($ MILLION)
FIGURE 19.    MEXICO SMART PILLS MARKET, 2017-2025 ($ MILLION)
FIGURE 20.    GERMANY SMART PILLS MARKET, 2017-2025 ($ MILLION)
FIGURE 21.    FRANCE SMART PILLS MARKET, 2017-2025 ($ MILLION)
FIGURE 22.    UK SMART PILLS MARKET, 2017-2025 ($ MILLION)
FIGURE 23.    ITALY SMART PILLS MARKET, 2017-2025 ($ MILLION)
FIGURE 24.    SPAIN SMART PILLS MARKET, 2017-2025 ($ MILLION)
FIGURE 25.    RUSSIA SMART PILLS MARKET, 2017-2025 ($ MILLION)
FIGURE 26.    REST OF EUROPE SMART PILLS MARKET, 2017-2025 ($ MILLION)
FIGURE 27.    JAPAN SMART PILLS MARKET, 2017-2025 ($ MILLION)
FIGURE 28.    CHINA SMART PILLS MARKET, 2017-2025 ($ MILLION)
FIGURE 29.    INDIA SMART PILLS MARKET, 2017-2025 ($ MILLION)
FIGURE 30.    AUSTRALIA SMART PILLS MARKET, 2017-2025 ($ MILLION)
FIGURE 31.    AUSTRALIA SMART PILLS MARKET, 2017-2025 ($ MILLION)
FIGURE 32.    TAIWAN SMART PILLS MARKET, 2017-2025 ($ MILLION)
FIGURE 33.    REST OF ASIA-PACIFIC SMART PILLS MARKET, 2017-2025 ($ MILLION)
FIGURE 34.    BRAZIL SMART PILLS MARKET, 2017-2025 ($ MILLION)
FIGURE 35.    SOUTH AFRICA SMART PILLS MARKET, 2017-2025 ($ MILLION)
FIGURE 36.    SAUDI ARABIA SMART PILLS MARKET, 2017–2025 ($MILLION)
FIGURE 37.    ARGENTINA SMART PILLS MARKET, 2017–2025 ($MILLION)
FIGURE 38.    REST OF LAMEA SMART PILLS MARKET, 2017–2025 ($MILLION)
FIGURE 39.    INTROMEDIC, 2015–2017 ($MILLION)
FIGURE 40.    PHILIPS: NET SALES, 2015–2017 ($MILLION)
FIGURE 41.    PHILIPS: REVENUE SHARE BY SEGMENT, 2017 (%)
FIGURE 42.    PHILIPS: REVENUE SHARE BY GEOGRAPHY, 2017 (%)
FIGURE 43.    MEDTRONIC, 2015–2017 ($MILLION)
FIGURE 44.    MEDTRONIC: REVENUE SHARE BY SEGMENT, 2017 (%)
FIGURE 45.    MEDTRONIC: REVENUE SHARE BY GEOGRAPHY, 2017 (%)
FIGURE 46.    OLYMPUS: REVENUE, 2015–2017 ($MILLION)
FIGURE 47.    OLYMPUS: REVENUE SHARE BY SEGMENT, 2017 (%)
FIGURE 48.    OLYMPUS: REVENUE SHARE BY GEOGRAPHY, 2017 (%)

 

 
 

PURCHASE OPTIONS

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Reach out to us

Call us on
( U.S. - Canada toll free )
+1-800-792-5285,    Int'l : +1-503-894-6022
Drop us an email at
help@alliedmarketresearch.com

Send Enquiry
 

Request Sample

Request Customization

Request sample

OR

Purchase Full Report of
Smart Pills Technology Market- Global Opportunity Analysis and Industry Forecast, 2014 - 2020

  • Online Only
  • $3690
  • Online cloud Access only
  • Restricted Print, copy, paste,download
  • Read Only
  • 20% free customization (Pre-Sale)
  •   Free quartery industry update
  •   Free report update (Within 180 days)
  •   Subscription Model Sign In
  • Data Pack
  • $4099
  • Restricted to one authorized users
  • One print only
  • Available in Excel
  • 20% free customization (Pre-Sale)
  •   Free quartery industry update
  •   Free report update (Within 180 days)
  •   Subscription Model Sign In
  • Single User
  • $4999
  • Restricted to one authorized users
  • One print only
  • Available in Excel & PDF
  • 20% free customization (Pre-Sale)
  •   Free quartery industry update
  •   Free report update (Within 180 days)
  •   Subscription Model Sign In
  • Five User
  • $6004
  • Limited to 5 authorized users
  • Print Upto Five Copies
  • Available in Excel & PDF
  • 20% free customization (Pre-Sale)
  •   Free quartery industry update
  •   Free report update (Within 180 days)
  •   Subscription Model Sign In
  • Enterprise
    License/PDF

  • $8373
  • Unlimited within company/enterprise
  • Unlimited within company/enterprise
  • Available in Excel & PDF
  • 20% free customization (Pre-Sale)
  •   Free quartery industry update
  •   Free report update (Within 180 days)
  •   Subscription Model Sign In

*Taxes/Fees, if applicable will be added during checkout. All prices in USD

 

HAVE QUESTIONS?
SPEAK WITH ANALYST

 
 

FREQUENTLY ASKED
QUESTIONS?

 
 

DID YOU MISS ANYTHING?
DO YOU HAVE SPECIFIC REQUIREMENTS?

 
 
 

Why Allied Market Research

 

Infallible Methodology

To ensure high level data integrity, accurate analysis and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers

 
 

Featured Reports

 
 

Featured Readings

 

Get Fresh content delivered

Get insights on topics that are crucial for your business. Stay abreast of your interest areas.

 
Get Industry Data Alerts
 

Access reports on all emerging
market of Life Sciences on Knowledge Tree Platform
Free Demo